ORYZON to Present at the Neuroscience R&D Technologies Conference

BARCELONA, Spain and CAMBRIDGE, Mass., Nov. 30, 2015 (GLOBE NEWSWIRE) — Oryzon Genomics, a clinical stage biopharmaceutical company leveraging epigenetics to develop therapies in oncology and neurodegenerative diseases, announced today that Dr. Tamara Maes, Oryzon’s Chief Scientific Officer, will present at the Neuroscience R&D Technologies Conference on December 3 – 4, to be held at Hotel Pullman Barcelona Skipper in Barcelona, Spain.Dr. Maes will be delivering a presentation on the “Role of epigenetics in neurodegenerative disease in general and development of LSD1 inhibitors in particular” on Friday, December 4 at 14:05 pm-14:35 pm. The presentation is part of a broader session that will discuss the recent advancements in next generation neuroscience research.”LSD1 inhibitors represent a novel approach to potential treatments of neurodegenerative diseases. We are very excited to share our…


Link to Full Article: ORYZON to Present at the Neuroscience R&D Technologies Conference